Abstract

CLAVIJO COHEN, Germán. The Risks for Women Associated with the Dispensation of Cyclofem in Pharmacies of Bogotá D.C. A Scope Review. Mem. Inst. Investig. Cienc. Salud [online]. 2018, vol.16, n.2, pp.100-106. ISSN 1812-9528.  https://doi.org/10.18004/mem.iics/1812-9528/2018.016(02)100-106.

The legal regulations in Colombia require that the dispensing and administration of Cyclofem in drugstores be supported by a medical prescription. Cyclofem is an injectable intramuscular combination contraceptive (CCI) that contains medroxyprogesterone acetate and estradiol cypionate with an effectiveness of 99.7%. This medication causes heavy, prolonged and irregular bleeding, queasiness, dizziness, weight gain, headache, osteoporosis and increases glucose tolerance and insulin resistance. Only 0.4% of the pharmacies in Bogotá D.C. demanded the presentation of the medical prescription for dispensing and intramuscular administration (I.M) of Cyclofem in accordance with the current legal regulations.

Keywords : drugstores; Cyclofem; medical prescription; dispensation; intramuscular administration.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )